Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$959.84K$959.84Kderived−18.4% vs Q4 2013 Net Income-$1.91M-$1.91MderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$2,678,738N/M Operating Cash Flowderived-$1,994,016N/M Free Cash Flowderived-$2,030,555N/M Margins · derivedOperating margin-279.1%−103.3 pt vs Q4 2013
Net margin-199.5%−53.6 pt vs Q4 2013
ended Dec 31, 2014 · filed Mar 17, 2015 · 76 d after period end